Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.2%

2 terminated/withdrawn out of 164 trials

Success Rate

95.0%

+8.5% vs industry average

Late-Stage Pipeline

18%

30 trials in Phase 3/4

Results Transparency

5%

2 of 38 completed trials have results

Key Signals

41 recruiting2 with results

Enrollment Performance

Analytics

N/A
38(35.5%)
Phase 2
26(24.3%)
Phase 3
15(14.0%)
Phase 4
15(14.0%)
Early Phase 1
7(6.5%)
Phase 1
6(5.6%)
107Total
N/A(38)
Phase 2(26)
Phase 3(15)
Phase 4(15)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (164)

Showing 20 of 164 trials
NCT07532122Completed

Postoperative Anxiety and Depression Among Chinese Elderly Patients

Role: collaborator

NCT07524699Not ApplicableNot Yet Recruiting

A Study About Remote and Local Liver Surgery

Role: collaborator

NCT07518810Phase 2Not Yet Recruiting

Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy

Role: collaborator

NCT07517510Phase 2Enrolling By Invitation

HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).

Role: collaborator

NCT03653156Recruiting

China Cognition and Aging Study

Role: collaborator

NCT03657732Recruiting

The Chinese Familial Alzheimer's Network

Role: collaborator

NCT07475936Not Yet Recruiting

Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke

Role: lead

NCT07475949Phase 3Not Yet Recruiting

Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging

Role: lead

NCT07459296Phase 3Recruiting

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Role: lead

NCT06343090Not ApplicableRecruiting

Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients

Role: collaborator

NCT06316856Phase 1Recruiting

CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies

Role: collaborator

NCT04713358Phase 4Completed

Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia

Role: collaborator

NCT06484374Not ApplicableRecruiting

A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke: Large Basal Ganglia Hemorrhage

Role: collaborator

NCT07405346Not ApplicableEnrolling By Invitation

A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy

Role: collaborator

NCT07406139Phase 4Recruiting

PCC Treatment for Hemophilia Patients With Inhibitor(2022PCC-A)

Role: collaborator

NCT06024876Early Phase 1Completed

A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia

Role: collaborator

NCT07130955Not ApplicableEnrolling By Invitation

A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease

Role: collaborator

NCT06685536Enrolling By Invitation

A Long-term Follow-up Study in Participants Who Received CS-101

Role: collaborator

NCT06565026Early Phase 1Recruiting

CS-206 in Patients With Sickle Cell Disease

Role: collaborator

NCT06328764Early Phase 1Enrolling By Invitation

CS-101 in Patients With β-thalassemia

Role: collaborator